Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
FRES	FRESH2 GROUP LTD	China	$3.80M	179,643,565	0.02%	38.84%
XRTX	XORTX THERAPEUTICS INC	Canada	$5.04M	1,998,848	100.00%	0.00%
ALNY	ALNYLAM PHARMACEUTICALS INC	United States	$19.03B	126,491,778	80.88%	19.12%	Net Selling	Net Selling
AIM	AIM IMMUNOTECH INC	United States	$19.96M	49,901,177	8.32%	10.11%	Net Buying	Net Buying
SNGX	SOLIGENIX INC	United States	$6.30M	15,799,837	0.36%	99.64%
PHG	KONINKLIJKE PHILIPS NV	Netherlands	$24.36B	906,403,156	7.56%	0.00%
VTRS	VIATRIS INC	United States	$13.29B	1,190,675,819	80.49%	17.86%	Net Selling	Net Selling
QDEL	QUIDELORTHO CORP	United States	$2.85B	66,971,816	74.34%	25.66%	Net Selling	Net Buying
IRWD	IRONWOOD PHARMACEUTICALS INC	United States	$1.11B	158,957,123	72.14%	27.86%	Net Selling	Net Buying
SINT	SINTX TECHNOLOGIES INC	United States	$907.21k	22,680,139	0.50%	12.68%
AUNA	AUNA SA	Luxembourg	N/A	73,917,577	0.00%	0.00%
SNTI	SENTI BIOSCIENCES INC	United States	$16.88M	45,755,021	25.05%	52.51%
ICCT	ICORECONNECT INC	United States	$13.30M	10,150,753	2.95%	0.00%
GENE	GENETIC TECHNOLOGIES LTD	Australia	$528.61k	115,417,246	0.02%	0.00%
CYTH	CYCLO THERAPEUTICS INC	United States	$42.21M	28,715,740	1.90%	98.10%	Net Buying
CTSO	CYTOSORBENTS CORP	United States	$49.42M	54,306,415	33.04%	50.28%	Net Buying
CGEN	COMPUGEN LTD	Israel	$177.71M	88,415,382	11.98%	0.00%
CGC	CANOPY GROWTH CORP	Canada	$824.59M	91,114,604	2.68%	97.32%	Net Selling
INMB	INMUNE BIO INC	United States	$198.22M	19,782,429	11.58%	37.05%	Net Buying	Net Buying
MYNZ	MAINZ BIOMED NV	Germany	$13.97M	21,165,482	1.10%	0.00%
TRVN	TREVENA INC	United States	$7.62M	18,321,010	7.63%	92.37%	Net Buying
CELU	CELULARITY INC	United States	$57.17M	19,378,164	5.49%	94.51%	Net Buying	Net Selling
MRAI	MARPAI INC	United States	$23.09M	10,308,038	2.30%	79.80%	Net Buying	Net Buying
AORT	ARTIVION INC	United States	$982.01M	41,734,442	76.80%	23.20%	Net Selling	Net Selling
BIAF	BIOAFFINITY TECHNOLOGIES INC	United States	$23.03M	11,514,354	1.36%	37.32%	Net Buying	Net Buying
CYTK	CYTOKINETICS INC	United States	$6.51B	104,853,918	88.32%	11.68%	Net Selling	Net Selling
GYRE	GYRE THERAPEUTICS INC	United States	$1.27B	85,423,246	0.37%	99.63%	Net Buying	Net Buying
GNLX	GENELUX CORP	United States	$103.40M	26,996,740	21.43%	5.19%	Net Selling	Net Selling
TNON	TENON MEDICAL INC	United States	$3.31M	3,726,974	15.07%	83.09%	Net Buying
APDN	APPLIED DNA SCIENCES INC	United States	$3.40M	984,728	11.48%	88.52%
STXS	STEREOTAXIS INC	United States	$179.04M	82,128,762	25.73%	74.27%	Net Buying
BOLD	BOUNDLESS BIO INC	United States	N/A	22,239,333	0.00%	23.98%	Net Buying	Net Buying
ANRO	ALTO NEUROSCIENCE INC	United States	$362.66M	26,883,988	0.00%	24.97%	Net Buying	Net Buying
NVCT	NUVECTIS PHARMA INC	United States	$117.48M	18,356,060	8.24%	49.25%	Net Buying	Net Buying
OGEN	ORAGENICS INC	United States	$8.24M	4,480,693	0.16%	99.84%	Net Selling
PHIO	PHIO PHARMACEUTICALS CORP	United States	$3.24M	4,591,700	0.49%	99.51%	Net Buying	Net Selling
ACON	ACLARION INC	United States	$1.98M	7,153,500	8.69%	19.80%
PMD	PSYCHEMEDICS CORP	United States	$14.64M	5,742,761	22.46%	50.15%	Net Selling
CTLT	CATALENT INC	United States	$10.10B	180,979,849	79.66%	20.34%	Net Buying	Net Selling
SCPX	SCORPIUS HOLDINGS INC	United States	$6.38M	36,031,964	4.71%	17.31%
PROK	PROKIDNEY CORP	United States	$651.07M	231,698,039	12.68%	8.89%	Net Selling	Net Selling
ATEC	ALPHATEC HOLDINGS INC	United States	$1.61B	139,883,919	21.41%	78.59%	Net Selling	Net Selling
AHG	AKSO HEALTH GROUP	China	$15.53M	68,598,050	0.40%	0.00%
VIRX	VIRACTA THERAPEUTICS INC	United States	$29.85M	39,272,434	3.63%	96.37%	Net Buying	Net Selling
PRTG	PORTAGE BIOTECH INC	Canada	$4.98M	19,778,000	11.46%	0.00%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	United States	$44.14M	250,816,164	10.20%	11.91%
NAMS	NEWAMSTERDAM PHARMA CO NV	Netherlands	$1.93B	89,976,538	60.05%	39.95%	Net Selling	Net Selling
KALA	KALA BIO INC	United States	$19.43M	2,816,454	1.06%	98.94%	Net Selling
VRPX	VIRPAX PHARMACEUTICALS INC	United States	$2.99M	1,171,233	4.26%	95.74%
KALV	KALVISTA PHARMACEUTICALS INC	United States	$509.63M	42,188,296	48.19%	51.81%	Net Buying	Net Selling
MBOT	MICROBOT MEDICAL INC	United States	$13.29M	14,398,964	4.57%	95.43%
AVBP	ARRIVENT BIOPHARMA INC	United States	$592.84M	33,493,750	0.00%	31.26%	Net Buying
AVGR	AVINGER INC	United States	$6.47M	1,702,226	1.27%	98.73%	Net Selling
XTLB	XTL BIOPHARMACEUTICALS LTD	United States	$13.95M	544,906,149	0.04%	20.78%
RVP	RETRACTABLE TECHNOLOGIES INC	United States	$32.63M	29,937,159	6.47%	93.53%	Net Buying	Net Buying
OPK	OPKO HEALTH INC	United States	$892.15M	696,991,677	17.43%	82.57%	Net Buying	Net Buying
BCDA	BIOCARDIA INC	United States	$10.59M	26,732,542	1.04%	98.96%	Net Buying	Net Buying
KOD	KODIAK SCIENCES INC	United States	$189.56M	52,508,602	67.33%	32.67%	Net Selling
ANL	ADLAI NORTYE LTD	United States	$481.07M	110,700,805	0.06%	0.00%
NMRA	NEUMORA THERAPEUTICS INC	United States	$1.47B	159,523,997	21.44%	78.56%	Net Buying
CMMB	CHEMOMAB THERAPEUTICS LTD	Israel	$11.93M	284,379,960	0.99%	5.95%
ASMB	ASSEMBLY BIOSCIENCES INC	United States	$73.88M	5,513,308	23.44%	76.56%	Net Buying	Net Selling
SANA	SANA BIOTECHNOLOGY INC	United States	$1.67B	221,502,908	47.20%	52.80%	Net Buying	Net Selling
INTS	INTENSITY THERAPEUTICS INC	United States	$54.85M	13,711,877	0.00%	14.62%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	Hong Kong	$72.35M	13,012,866	0.13%	0.00%
TPST	TEMPEST THERAPEUTICS INC	United States	$72.21M	22,217,265	4.15%	95.85%
ILMN	ILLUMINA INC	United States	$17.61B	159,300,000	89.06%	1.98%	Net Selling	Net Buying
AIMD	AINOS INC	United States	$6.26M	5,954,317	0.13%	99.87%	Net Buying	Net Buying
CARA	CARA THERAPEUTICS INC	United States	$39.13M	54,656,413	44.64%	53.41%	Net Selling	Net Selling
PHVS	PHARVARIS NV	Netherlands	$1.15B	53,816,707	75.71%	0.00%
VERU	VERU INC	United States	$194.69M	146,383,920	40.81%	28.47%
BIOR	BIORA THERAPEUTICS INC	United States	$22.22M	30,313,428	10.45%	89.55%	Net Selling
IXHL	INCANNEX HEALTHCARE INC	Australia	$40.32M	15,873,113	1.72%	27.69%
GOSS	GOSSAMER BIO INC	United States	$167.85M	226,218,652	86.47%	13.53%	Net Buying	Net Selling
ESLA	ESTRELLA IMMUNOPHARMA INC	United States	$39.54M	36,610,870	0.35%	80.34%	Net Selling
LUCD	LUCID DIAGNOSTICS INC	United States	$45.54M	48,244,798	3.62%	72.58%	Net Buying
CERE	CEREVEL THERAPEUTICS HOLDINGS INC	United States	$7.69B	182,194,722	26.94%	73.06%	Net Buying	Net Buying
VANI	VIVANI MEDICAL INC	United States	$99.51M	54,978,000	2.51%	97.49%	Net Buying	Net Buying
CGON	CG ONCOLOGY INC	United States	$1.90B	66,640,150	0.00%	16.44%	Net Buying
CALC	CALCIMEDICA INC	United States	$60.14M	10,740,115	2.26%	97.74%	Net Buying	Net Buying
BSGM	BIOSIG TECHNOLOGIES INC	United States	$14.00M	11,198,174	49.15%	50.85%	Net Buying
EDSA	EDESA BIOTECH INC	Canada	$14.83M	3,215,968	1.29%	98.71%	Net Buying	Net Buying
LXEO	LEXEO THERAPEUTICS INC	United States	$432.90M	32,945,341	49.09%	20.74%	Net Buying
KYTX	KYVERNA THERAPEUTICS INC	United States	$603.61M	43,115,244	0.00%	51.65%	Net Buying
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	United States	$5.76M	2,249,290	2.04%	97.96%	Net Buying
CKPT	CHECKPOINT THERAPEUTICS INC	United States	$55.28M	36,850,279	13.26%	7.77%	Net Selling	Net Selling
RSLS	RESHAPE LIFESCIENCES INC	United States	$3.94M	23,457,090	1.86%	93.06%	Net Buying
FBLG	FIBROBIOLOGICS INC	United States	$303.17M	32,634,366	0.00%	0.39%
PLSE	PULSE BIOSCIENCES INC	United States	$411.43M	55,225,333	7.98%	78.41%	Net Buying
LFCR	LIFECORE BIOMEDICAL INC	United States	$191.83M	30,546,936	49.15%	50.85%
CPHI	CHINA PHARMA HOLDINGS INC	China	$4.77M	14,816,865	1.16%	98.84%	Net Buying
CRIS	CURIS INC	United States	$92.66M	5,894,085	3.46%	96.54%
IMNN	IMUNON INC	United States	$12.97M	9,399,789	4.47%	92.02%
NEXI	NEXIMMUNE INC	United States	$4.94M	1,371,051	1.34%	98.66%	Net Selling
APLM	APOLLOMICS INC	United States	$33.29M	89,495,790	9.89%	0.00%
REVB	REVELATION BIOSCIENCES INC	United States	$3.36M	1,632,935	8.80%	91.20%	Net Selling
CPIX	CUMBERLAND PHARMACEUTICALS INC	United States	$21.85M	14,191,229	15.49%	58.39%	Net Buying	Net Selling
RARE	ULTRAGENYX PHARMACEUTICAL INC	United States	$3.40B	83,133,341	83.47%	16.53%	Net Selling	Net Selling
CYBN	CYBIN INC	Canada	$148.86M	411,216,132	13.89%	0.00%
STSS	SHARPS TECHNOLOGY INC	United States	$3.60M	15,670,898	8.84%	23.64%	Net Buying	Net Buying

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	680	-1.62%	-2.51%	-3.52%	-21.05%	6.42x	5.91x	+20.97%	+3.56%	-33.88%	+84.90%	Strong Buy
Diagnostics & Research	66	+5.11%	+7.27%	+4.18%	+9.23%	37.39x	4.36x	-13.51%	+6.44%	+11.47%	+3.98%	Buy
Drug Manufacturers - General	17	-0.53%	+1.82%	+3.59%	+14.38%	31.93x	6.33x	+33.48%	+8.06%	+14.18%	+12.79%	Buy
Drug Manufacturers - Specialty & Generic	90	-0.72%	-1.27%	+0.66%	-6.21%	-3.15x	2.17x	+11.81%	+3.11%	+6.07%	+34.14%	Buy
Healthcare Plans	12	+0.39%	+3.48%	+3.54%	+2.41%	25.16x	3.02x	+15.17%	+4.73%	+11.77%	+13.27%	Buy
Health Information Services	59	-1.02%	-2.32%	-6.09%	-23.97%	12.79x	3.34x	+7.06%	+2.44%	+6.04%	+33.12%	Buy
Medical Care Facilities	51	+0.10%	+3.37%	+1.26%	+10.73%	39.75x	4.47x	-95.44%	+6.74%	+14.01%	+14.51%	Buy
Medical Devices	153	-0.47%	-1.92%	-4.16%	-14.44%	29.79x	3.92x	+7.18%	+5.22%	+7.62%	+21.81%	Buy
Medical Distribution	9	+0.59%	+3.79%	-0.11%	+28.86%	26.83x	110.00x	-10.56%	+3.43%	+19.55%	+9.31%	Buy
Medical Instruments & Supplies	56	+0.54%	+1.52%	-0.53%	-8.80%	58.36x	3.57x	+11.29%	+7.72%	+10.10%	+19.62%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -38.53% over the past year, underperforming other healthcare stocks by -31 percentage points.

Cross Country Healthcare has an average 1 year price target of $19.50, an upside of 30.61% from Cross Country Healthcare's current stock price of $14.93.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -5.48% over the past year, overperforming other healthcare stocks by 2 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 12.67% over the past year, overperforming other healthcare stocks by 20 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 50.4% from Corcept Therapeutics's current stock price of $27.04.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.95%, which is 55 percentage points higher than the healthcare sector average of 2.88%.

Mei Pharma's dividend payout ratio of 44.6% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 14.08%, which is 11 percentage points higher than the healthcare sector average of 2.88%.

Siga Technologies's dividend payout ratio of 95.5% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.36%, which is 5 percentage points higher than the healthcare sector average of 2.88%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.3% in the last day, and up 0.86% over the last week. Novavax was the among the top gainers in the healthcare sector, gaining 98.66% yesterday.

Novavax shares are trading higher after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and develop COVID-influenza combination vaccines.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -47.49% in the past year. It has underperformed other stocks in the healthcare sector by -40 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -31.41% in the past year. It has underperformed other stocks in the healthcare sector by -24 percentage points.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has dropped -5.48% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

Are healthcare stocks a good buy now?

48.62% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 35.12% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 26.88x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.